Detalhe da pesquisa
1.
Humoral response among patients with interstitial lung disease vaccinated with the BNT162b2 SARS-Cov-2 vaccine: a prospective cohort study.
Respir Res
; 23(1): 226, 2022 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36045374
2.
Antibody Titers Before and After a Third Dose of the SARS-CoV-2 BNT162b2 Vaccine in Adults Aged ≥60 Years.
JAMA
; 326(21): 2203-2204, 2021 12 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34739043
3.
Humoral and T-Cell Response before and after a Fourth BNT162b2 Vaccine Dose in Adults ≥60 Years.
J Clin Med
; 11(9)2022 May 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35566774
4.
Three-month follow-up of durability of response to the third dose of the SARS-CoV-2 BNT162b2 vaccine in adults aged 60 years and older: a prospective cohort study.
BMJ Open
; 12(8): e061584, 2022 08 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35918111
5.
Antibody Titers After a Third and Fourth SARS-CoV-2 BNT162b2 Vaccine Dose in Older Adults.
JAMA Netw Open
; 5(7): e2223090, 2022 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35862048